Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Revenues
Product sales		$ 109,200
Grant revenues	0	0
Total revenues		109,200
Cost of goods sold		(69,160)
Gross profit		40,040
Operating expenses
Research and development	(640,425)	(2,037,370)
Selling, general and administrative	(2,935,863)	(4,908,919)
Total operating expenses	(3,576,288)	(6,946,289)
Loss from operations	(3,576,288)	(6,906,249)
Other income (expenses):
Impairment loss on investment	(1,834,672)	0
Interest income		217
Interest expense	(94,576)	(771)
Total other expenses	(1,929,248)	(554)
Net loss from continuing operations	(5,505,536)	(6,906,803)
Net loss from discontinued operations		(2,007,490)
Net loss	(5,505,536)	(8,914,293)
Deemed dividend on preferred stock		(405,872)
Net loss applicable to common stockholders	$ (5,505,536)	$ (9,320,165)
Net loss per share-basic and diluted
Net loss from continued operations	$ (0.50)	$ (1.04)
Net Loss from discontinued operations	$ 0.00	$ (0.29)
Net loss per share-basic and diluted	$ (0.50)	$ (1.33)
Weighted average number of common shares outstanding - basic and diluted	11,121,871	6,995,676